Skip to content

Traditional Rehabilitation Versus Rehabilitation With the Imoove® Device for Spinal Musculoskeletal Disorders

Traditional Rehabilitation Versus Rehabilitation With the Imoove® Device for Spinal Musculoskeletal Disorders: a Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02116387
Acronym
IMOOVE IT
Enrollment
60
Registered
2014-04-16
Start date
2014-07-04
Completion date
2018-06-28
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Back Pain

Keywords

Proprioception

Brief summary

The main objective of this study is to evaluate in patients with chronic low back pain (lasting for more than 3 months and not postoperative) the effect of an instrumental rehabilitation using the I-Moove ® device compared to a conventional physiotherapy rehabilitation for ambulatory postural stability (mean and standard deviation of excursions from the center of gravity) without visual control, 6 weeks after the start of the rehabilitation protocol. We focus on the relative variation between the values obtained on day 0 versus 6 weeks, via measures performed on a force platform. The results will be stratified into 3 age groups (18-39 years, 40-60 years and over 60 years).

Detailed description

The secondary objectives of this study are to evaluate and compare the two physical therapy techniques at 6 weeks and 6 months after the start of the rehabilitation protocol in terms of: A - improving postural stability and visual control on an unstable surface (with and without visual control) B - improving levels of abdominal strength (Ito test) and erector spinae (Sørensen test) C - the impact of back pain on daily life using questionnaires (Dallas, Québec, FABQ and Tampa questionnaires/scores) D - Improvement of pain (Visual Analog Scale),

Interventions

OTHERRoutine Physical Therapy

Patients randomized to this arm will participate in a classic physical therapy program (15 weeks, a total of 15 sessions).

DEVICEI-Moove Physical Therapy

Patients randomized to this arm will participate in a physical therapy program using the I-Moove device (15 weeks, a total of 15 sessions).

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is available for 6 months of follow-up * Patients with pain in the lumbar spine (low back pain) for at least 3 months, not in connection with an operation

Exclusion criteria

* The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient will have difficulties with follow-up (the patient is about to move, or isn't motivated) * The patient is under judicial protection, under tutorship or curatorship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * The patient is pregnant, parturient, or breastfeeding * The patient has already participated in a dynamic physical therapy program * The patient has a contraindication for a treatment used in this study * The patient has had surgery in the past year * The patient has a pathology that can interfere with the physical therapy regimen (heart failure, respiratory failure, major orthopedic problems)

Design outcomes

Primary

MeasureTime frame
Change in postural stability on the platform, eyes closedBaseline to 6 weeks

Secondary

MeasureTime frameDescription
Change in postural stability on the platform, eyes openBaseline to 6 weeks
Change in postural stability on the platform, eyes open and with an unstable surfaceBaseline to 6 weeks
Change in postural stability on the platform, eyes closed and with an unstable surfaceBaseline to 6 weeks
Abdominal endurance: Ito testBaseline (day 0)
Sorensen testBaseline (day 0)
Change in postural stability on the platform, eyes closedBaseline to 6 months
Quebec questionnaireBaseline (day 0)
FABQ questionnaireBaseline (day 0)
Tampa ScoreBaseline (day 0)
Visual analog scale for painBaseline (day 0)ranging from 0 to 10
Dallas questionnaireBaseline (day 0)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026